AACR14 Apr 2018 10:50
Yes, it's taken a while but finally Parsortix is demonstrating things that we shareholders already believed were possible.
If we were listed on Nazdaq, this news alone would multibag our sp. AIM and UK markets are useless really.
When this is briefed if we get a 1-2p move and increased spread to boot, that will be it I think.
The real turning point will be FDA, maybe 6-7 months away. Surely then even on AIM we will hit the dizzy heights of �2!!
Of course if we were USA listed (not OTC) it would likely be �10 on FDA approval.